The stable traits of melanoma genetics: an alternate approach to target discovery
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2164
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The stable traits of melanoma genetics: an alternate approach to target discovery ; volume:13 ; number:1 ; day:26 ; month:4 ; year:2012 ; pages:1-11 ; date:12.2012
BMC genomics ; 13, Heft 1 (26.4.2012), 1-11, 12.2012
- Urheber
-
Spivey, Tara L.
- Beteiligte Personen und Organisationen
-
De Giorgi, Valeria
Zhao, Yingdong
Bedognetti, Davide
Pos, Zoltan
Liu, Qiuzhen
Tomei, Sara
Ascierto, Maria Libera
Uccellini, Lorenzo
Reinboth, Jennifer
Chouchane, Lotfi
Stroncek, David F.
Wang, Ena
Marincola, Francesco M.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2164-13-156
- URN
-
urn:nbn:de:1111-2016072837950
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Spivey, Tara L.
- De Giorgi, Valeria
- Zhao, Yingdong
- Bedognetti, Davide
- Pos, Zoltan
- Liu, Qiuzhen
- Tomei, Sara
- Ascierto, Maria Libera
- Uccellini, Lorenzo
- Reinboth, Jennifer
- Chouchane, Lotfi
- Stroncek, David F.
- Wang, Ena
- Marincola, Francesco M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
The stable traits of melanoma genetics: an alternate approach to target discovery
RNA amplification for successful gene profiling analysis
Translational medicine from observation to hypothesis to interpretation
Polymorphism in clinical immunology – From HLA typing to immunogenetic profiling
Changing paradigm through a genome-based approach to clinical and basic immunology
The challenge of studying complex diseases undergoing complex treatments: the metastatic cancer model
TLR2/6 agonists and IFNγ synergize to induce melanoma cells to produce T-cell recruiting chemokines
Translational Medicine is developing in China: A new venue for collaboration
Peritoneal inflammation – A microenvironment for Epithelial Ovarian Cancer (EOC)
Potency analysis of cellular therapies: the emerging role of molecular assays
Ovarian cancer, the coagulation pathway, and inflammation
Melanoma-restricted genes
The stable traits of melanoma genetics: an alternate approach to target discovery
RNA amplification for successful gene profiling analysis
Translational medicine from observation to hypothesis to interpretation
Polymorphism in clinical immunology – From HLA typing to immunogenetic profiling
Changing paradigm through a genome-based approach to clinical and basic immunology
The challenge of studying complex diseases undergoing complex treatments: the metastatic cancer model
TLR2/6 agonists and IFNγ synergize to induce melanoma cells to produce T-cell recruiting chemokines
Translational Medicine is developing in China: A new venue for collaboration
Peritoneal inflammation – A microenvironment for Epithelial Ovarian Cancer (EOC)
Potency analysis of cellular therapies: the emerging role of molecular assays
Ovarian cancer, the coagulation pathway, and inflammation
Melanoma-restricted genes
The stable traits of melanoma genetics: an alternate approach to target discovery
RNA amplification for successful gene profiling analysis
Translational medicine from observation to hypothesis to interpretation
Polymorphism in clinical immunology – From HLA typing to immunogenetic profiling
Changing paradigm through a genome-based approach to clinical and basic immunology
The challenge of studying complex diseases undergoing complex treatments: the metastatic cancer model
TLR2/6 agonists and IFNγ synergize to induce melanoma cells to produce T-cell recruiting chemokines
Translational Medicine is developing in China: A new venue for collaboration
Peritoneal inflammation – A microenvironment for Epithelial Ovarian Cancer (EOC)
Potency analysis of cellular therapies: the emerging role of molecular assays
Ovarian cancer, the coagulation pathway, and inflammation